NBI-98854
BR
- Product Code: 103156
CAS:
1639208-54-0
Molecular Weight: | 762.97 g./mol | Molecular Formula: | C₃₈H₅₄N₂O₁₀S₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
NBI-98854 is primarily used in the treatment of tardive dyskinesia, a neurological disorder characterized by repetitive, involuntary movements. It functions as a vesicular monoamine transporter 2 (VMAT2) inhibitor, which helps regulate dopamine levels in the brain, thereby reducing the severity of symptoms. This compound is particularly beneficial for patients who have developed tardive dyskinesia as a side effect of long-term antipsychotic medication. Its targeted mechanism of action minimizes the risk of exacerbating psychiatric conditions, making it a valuable therapeutic option for managing this challenging disorder.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿8,690.00 |
+
-
|
NBI-98854
NBI-98854 is primarily used in the treatment of tardive dyskinesia, a neurological disorder characterized by repetitive, involuntary movements. It functions as a vesicular monoamine transporter 2 (VMAT2) inhibitor, which helps regulate dopamine levels in the brain, thereby reducing the severity of symptoms. This compound is particularly beneficial for patients who have developed tardive dyskinesia as a side effect of long-term antipsychotic medication. Its targeted mechanism of action minimizes the risk of exacerbating psychiatric conditions, making it a valuable therapeutic option for managing this challenging disorder.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :